Cancer and antineoplastic therapies and the risk of infection in the pediatric cancer patient

Neil Patel; Abby Green

doi:10.1016/B978-0-323-64198-2.00012-9

Cancer and antineoplastic therapies and the risk of infection in the pediatric cancer patient

Research output: Chapter in Book/Report/Conference proceeding › Chapter › peer-review

Abstract

Children with cancer are at high risk for opportunistic infections due to immune deficits associated with malignancy and chemotherapy. A wide spectrum of malignancies arise in pediatric patients and treatment regimens are tailored to patient- and disease-specific characteristics. Thus, the risk for developing infectious diseases varies among pediatric oncology patients. This chapter provides information regarding common malignancies of childhood, treatment regimens and their side effects, and an approach to assessing risk of infection in children with cancer.

Original language	English
Title of host publication	Pediatric Transplant and Oncology Infectious Diseases
Publisher	Elsevier
Pages	22-33.e3
ISBN (Electronic)	9780323641982
DOIs	https://doi.org/10.1016/B978-0-323-64198-2.00012-9
State	Published - Jan 1 2020

Keywords

Chemotherapy
Childhood cancer
Immunotherapy
Opportunistic infections
Pediatric oncology
Stem cell transplantation

Access to Document

10.1016/B978-0-323-64198-2.00012-9

Cite this

@inbook{72b10dc7fdf14cd2a756f4392e9f9611,

title = "Cancer and antineoplastic therapies and the risk of infection in the pediatric cancer patient",

abstract = "Children with cancer are at high risk for opportunistic infections due to immune deficits associated with malignancy and chemotherapy. A wide spectrum of malignancies arise in pediatric patients and treatment regimens are tailored to patient- and disease-specific characteristics. Thus, the risk for developing infectious diseases varies among pediatric oncology patients. This chapter provides information regarding common malignancies of childhood, treatment regimens and their side effects, and an approach to assessing risk of infection in children with cancer.",

keywords = "Chemotherapy, Childhood cancer, Immunotherapy, Opportunistic infections, Pediatric oncology, Stem cell transplantation",

author = "Neil Patel and Abby Green",

year = "2020",

month = jan,

day = "1",

doi = "10.1016/B978-0-323-64198-2.00012-9",

language = "English",

pages = "22--33.e3",

booktitle = "Pediatric Transplant and Oncology Infectious Diseases",

publisher = "Elsevier",

}

TY - CHAP

T1 - Cancer and antineoplastic therapies and the risk of infection in the pediatric cancer patient

AU - Patel, Neil

AU - Green, Abby

PY - 2020/1/1

Y1 - 2020/1/1

N2 - Children with cancer are at high risk for opportunistic infections due to immune deficits associated with malignancy and chemotherapy. A wide spectrum of malignancies arise in pediatric patients and treatment regimens are tailored to patient- and disease-specific characteristics. Thus, the risk for developing infectious diseases varies among pediatric oncology patients. This chapter provides information regarding common malignancies of childhood, treatment regimens and their side effects, and an approach to assessing risk of infection in children with cancer.

AB - Children with cancer are at high risk for opportunistic infections due to immune deficits associated with malignancy and chemotherapy. A wide spectrum of malignancies arise in pediatric patients and treatment regimens are tailored to patient- and disease-specific characteristics. Thus, the risk for developing infectious diseases varies among pediatric oncology patients. This chapter provides information regarding common malignancies of childhood, treatment regimens and their side effects, and an approach to assessing risk of infection in children with cancer.

KW - Chemotherapy

KW - Childhood cancer

KW - Immunotherapy

KW - Opportunistic infections

KW - Pediatric oncology

KW - Stem cell transplantation

UR - http://www.scopus.com/inward/record.url?scp=85124855687&partnerID=8YFLogxK

U2 - 10.1016/B978-0-323-64198-2.00012-9

DO - 10.1016/B978-0-323-64198-2.00012-9

M3 - Chapter

AN - SCOPUS:85124855687

SP - 22-33.e3

BT - Pediatric Transplant and Oncology Infectious Diseases

PB - Elsevier

ER -

Cancer and antineoplastic therapies and the risk of infection in the pediatric cancer patient

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this